PMV Pharmaceuticals, Inc. — Director's Dealing 2023

May 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2023-05-12

Reporting Person: Alland Leila (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-12	Employee Stock Option (right to buy)	$5.70	A	100000	Acquired	2033-05-12	Common Stock (100000)	Direct

Footnotes

F1: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.